Caxton Associates (UK)’s Sempra SRE Stock Holding History
Bought
Maintained
Sold
Other funds holding SRE
Caxton Associates (UK)'s SRE Position: Q2 2026 in Review
Caxton Associates (UK) sold out of Sempra (SRE) in Q2 2026, closing a stake of 3,612 shares — an estimated $351K sold.
Caxton Associates (UK) first reported a position in SRE in Q1 2025 and held it in 2 quarters. The position peaked at $449K in Q1 2025. 1,282 funds tracked by Wall St. Rank hold SRE as of Q2 2026.
- Caxton Associates (UK) reported no remaining Sempra position as of Q2 2026 after selling out during the quarter.
- Caxton Associates (UK) sold 3,612 Sempra shares in Q2 2026, an estimated $351K.
- Caxton Associates (UK) first reported a position in Sempra in Q1 2025 and held it in 2 quarters.
- Caxton Associates (UK)'s Sempra position peaked at $449K in Q1 2025.
- 1,282 funds tracked by Wall St. Rank held Sempra as of Q2 2026.
Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.